BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34976071)

  • 1. PTHG2 Reduces Bone Loss in Ovariectomized Mice by Directing Bone Marrow Mesenchymal Stem Cell Fate.
    Chen J; Zhang H; Wu X; Wang F; Wang Y; Gao Q; Liu H; Hu Y; Su J; Jing Y
    Stem Cells Int; 2021; 2021():8546739. PubMed ID: 34976071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intermittent parathyroid hormone (1-34) application regulates cAMP-response element binding protein activity to promote the proliferation and osteogenic differentiation of bone mesenchymal stromal cells, via the cAMP/PKA signaling pathway.
    Chen B; Lin T; Yang X; Li Y; Xie D; Cui H
    Exp Ther Med; 2016 Jun; 11(6):2399-2406. PubMed ID: 27284327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells.
    Rickard DJ; Wang FL; Rodriguez-Rojas AM; Wu Z; Trice WJ; Hoffman SJ; Votta B; Stroup GB; Kumar S; Nuttall ME
    Bone; 2006 Dec; 39(6):1361-72. PubMed ID: 16904389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.
    Shen G; Ren H; Shang Q; Zhao W; Zhang Z; Yu X; Tang K; Tang J; Yang Z; Liang D; Jiang X
    EBioMedicine; 2020 Feb; 52():102626. PubMed ID: 31981979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of parathyroid hormone 1-34 on the osteogenic characteristics of adipose- and bone-marrow-derived mesenchymal stem cells from juvenile and ovarectomized rats.
    Osagie-Clouard L; Sanghani-Kerai A; Coathup M; Meeson R; Briggs T; Blunn G
    Bone Joint Res; 2019 Aug; 8(8):397-404. PubMed ID: 31537997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The lncRNA H19/miR-541-3p/Wnt/β-catenin axis plays a vital role in melatonin-mediated osteogenic differentiation of bone marrow mesenchymal stem cells.
    Han H; Tian T; Huang G; Li D; Yang S
    Aging (Albany NY); 2021 Jul; 13(14):18257-18273. PubMed ID: 34311444
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Long Non-coding RNA-ORLNC1 Regulates Bone Mass by Directing Mesenchymal Stem Cell Fate.
    Yang L; Li Y; Gong R; Gao M; Feng C; Liu T; Sun Y; Jin M; Wang D; Yuan Y; Yan G; He M; Idiiatullina E; Ma W; Han Z; Zhang L; Huang Q; Ding F; Cai B; Yang F
    Mol Ther; 2019 Feb; 27(2):394-410. PubMed ID: 30638773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Morusin induces osteogenic differentiation of bone marrow mesenchymal stem cells by canonical Wnt/β-catenin pathway and prevents bone loss in an ovariectomized rat model.
    Chen M; Han H; Zhou S; Wen Y; Chen L
    Stem Cell Res Ther; 2021 Mar; 12(1):173. PubMed ID: 33712069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icariin promotes osteogenic differentiation of bone marrow stromal cells and prevents bone loss in OVX mice via activating autophagy.
    Liang X; Hou Z; Xie Y; Yan F; Li S; Zhu X; Cai L
    J Cell Biochem; 2019 Aug; 120(8):13121-13132. PubMed ID: 30887562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-203 is essential for the shift from osteogenic differentiation to adipogenic differentiation of mesenchymal stem cells in postmenopausal osteoporosis.
    Qiao L; Liu D; Li CG; Wang YJ
    Eur Rev Med Pharmacol Sci; 2018 Sep; 22(18):5804-5814. PubMed ID: 30280759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Intermittent Parathyroid Hormone 1-34 Administration on Circulating Mesenchymal Stem Cells in Postmenopausal Osteoporotic Women.
    Tang Y; Xia H; Kang L; Sun Q; Su Z; Hao C; Xue Y
    Med Sci Monit; 2019 Jan; 25():259-268. PubMed ID: 30620727
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pilose antler aqueous extract promotes the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells by stimulating the BMP-2/Smad1, 5/Runx2 signaling pathway.
    Ren C; Gong W; Li F; Xie M
    Chin J Nat Med; 2019 Oct; 17(10):756-767. PubMed ID: 31703756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Icariin recovers the osteogenic differentiation and bone formation of bone marrow stromal cells from a rat model of estrogen deficiency-induced osteoporosis.
    Luo Z; Liu M; Sun L; Rui F
    Mol Med Rep; 2015 Jul; 12(1):382-8. PubMed ID: 25695835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extracellular vesicles from GPNMB-modified bone marrow mesenchymal stem cells attenuate bone loss in an ovariectomized rat model.
    Huang B; Su Y; Shen E; Song M; Liu D; Qi H
    Life Sci; 2021 May; 272():119208. PubMed ID: 33582177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human umbilical cord mesenchymal stromal cells-derived extracellular vesicles exert potent bone protective effects by CLEC11A-mediated regulation of bone metabolism.
    Hu Y; Zhang Y; Ni CY; Chen CY; Rao SS; Yin H; Huang J; Tan YJ; Wang ZX; Cao J; Liu ZZ; Xie PL; Wu B; Luo J; Xie H
    Theranostics; 2020; 10(5):2293-2308. PubMed ID: 32089743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of osteogenic and adipogenic potential in bone marrow-derived mesenchymal stem cells under osteoporosis.
    Huang T; Yu Z; Yu Q; Wang Y; Jiang Z; Wang H; Yang G
    Biochem Biophys Res Commun; 2020 May; 525(4):902-908. PubMed ID: 32171528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Parathyroid Hormone Directs Bone Marrow Mesenchymal Cell Fate.
    Fan Y; Hanai JI; Le PT; Bi R; Maridas D; DeMambro V; Figueroa CA; Kir S; Zhou X; Mannstadt M; Baron R; Bronson RT; Horowitz MC; Wu JY; Bilezikian JP; Dempster DW; Rosen CJ; Lanske B
    Cell Metab; 2017 Mar; 25(3):661-672. PubMed ID: 28162969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-derived stem cells alleviate osteoporosis by enhancing osteogenesis and inhibiting adipogenesis in a rabbit model.
    Ye X; Zhang P; Xue S; Xu Y; Tan J; Liu G
    Cytotherapy; 2014 Dec; 16(12):1643-55. PubMed ID: 25231892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intermittent weekly administration of human parathyroid hormone (1-34) improves bone-hydroxyapatite block bonding in ovariectomized rats.
    Kamo K; Miyakoshi N; Kasukawa Y; Nozaka K; Sasaki H; Shimada Y
    J Bone Miner Metab; 2010 Nov; 28(6):634-40. PubMed ID: 20376511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parathyroid Hormone Shifts Cell Fate of a Leptin Receptor-Marked Stromal Population from Adipogenic to Osteoblastic Lineage.
    Yang M; Arai A; Udagawa N; Zhao L; Nishida D; Murakami K; Hiraga T; Takao-Kawabata R; Matsuo K; Komori T; Kobayashi Y; Takahashi N; Isogai Y; Ishizuya T; Yamaguchi A; Mizoguchi T
    J Bone Miner Res; 2019 Oct; 34(10):1952-1963. PubMed ID: 31173642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.